The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Treatment of Preterm Labor with the Beta-Adrenergic Agonist Ritodrine
Open accessAbstract
BACKGROUND: Beta-adrenergic agonists are commonly used to arrest premature labor. Although treatment of preterm labor with these agents can delay delivery by 24 to 48 hours, the potential risks and benefits to the mother and infant before and after delivery have not been adequately assessed. METHODS: We randomly assigned 708 women with preterm labor at six hospitals to receive an intravenous infusion of either the beta-adrenergic agonist ritodrine (n = 352) or placebo (n = 356). Assignment was made with stratification according to four categories of gestational age (20 to 23 weeks, 24 to 27 weeks, 28 to 31 weeks, and 32 to 35 weeks). The primary objective was to assess the effect of ritodrine on perinatal mortality. Secondary objectives were the evaluation of the causes of perinatal death, the extent to which delivery was delayed with ritodrine, and the effects on birth weight, maternal morbidity, neonatal morbidity, and infant morbidity at 18 months of postnatal age, corrected for preterm delivery. RESULTS: Among the 771 infants born to the women in the study (including 63 pairs of twins), there were 23 deaths (6.1 percent) in the ritodrine group and 25 deaths (6.4 percent) in the placebo group (event-rate difference, -0.3 percent; 95 percent confidence interval, -3.7 percent to 3.1 percent). There was no difference between the groups in the extent of delay of delivery, the incidence of delivery before 37 weeks' gestation, the proportion of babies weighing less than 2500 g, or measures of neonatal morbidity. Maternal morbidity (such as chest pain and cardiac arrhythmias) occurred more frequently but not exclusively in the ritodrine group. One infant born to a woman in the ritodrine group and five infants born to women in the placebo group had cerebral palsy (P = 0.09). There was a slight but not significant trend toward an improved score on the Bayley Psychomotor Development Index at 18 months of age among the infants of the ritodrine-treated women. CONCLUSIONS: We found that the use of ritodrine in the treatment of preterm labor had no significant beneficial effect on perinatal mortality, the frequency of prolongation of pregnancy to term, or birth weight.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Beta‐mimetics in preterm labour: an overview of the randomized controlled trials
KING, J. F., GRANT, A., KEIRSE, M. J. N. C., & CHALMERS, I. (1988) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1988.tb06860.x · Cited by 330
Cited by
Goldenberg, R. L., & Rouse, D. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390506 · Cited by 758
Slattery, M. M., & Morrison, J. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11476-0 · Cited by 675
Hay, P. E., Lamont, R. F., Taylor-Robinson, D., Morgan, D. J., Ison, C., & Pearson, J. (1994) · BMJ · doi:10.1136/bmj.308.6924.295 · Cited by 651
Classification and heterogeneity of preterm birth
MOUTQUIN, J. (2003) · BJOG: An International Journal of Obstetrics and Gynaecology · doi:10.1016/s1470-0328(03)00021-1 · Cited by 449
Rouget, C., Breuiller‐Fouché, M., Mercier, F. J., Leroy, M. J., Loustalot, C., Naline, E., Frydman, R., Croci, T., Morcillo, E. J., Advenier, C., et al. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705616 · Cited by 31
Metadata
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1992-07-30
- Volume
- 327
- Issue
- 5
- Pages
- 308-312
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4248096658
- Cited by
- 380
- References
- 1
- FWCI
- 22.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of Preterm Labor with the Beta-Adrenergic Agonist Ritodrine. https://app.cochat.ai/papers/10.1056/nejm199207303270503
- The paper
- Treatment of Preterm Labor with the Beta-Adrenergic Agonist Ritodrine. (1992). New England Journal of Medicine. https://doi.org/10.1056/nejm199207303270503
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.